This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriyama, B.
Right arrow Articles by Walsh, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriyama, B.
Right arrow Articles by Walsh, T. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CIMETIDINE

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2009, p. 1712-1714, Vol. 53, No. 4
0066-4804/09/$08.00+0     doi:10.1128/AAC.01221-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine{triangledown}

Brad Moriyama,1 Jason Elinoff,2 Robert L. Danner,2 Juan Gea-Banacloche,3 Gennethel Pennick,4 Michael G. Rinaldi,4 and Thomas J. Walsh3*

NIH Clinical Center Pharmacy Dept., Bethesda, Maryland,1 Critical Care Medicine Department, Bethesda, Maryland,2 National Cancer Institute, Bethesda, Maryland,3 University of Texas Health Science Center, San Antonio, Texas4

Received 15 September 2008/ Returned for modification 22 November 2008/ Accepted 19 January 2009

We report a case of accelerated metabolism of voriconazole during therapy for invasive pulmonary aspergillosis, resulting in subtherapeutic levels. Target voriconazole levels were restored with high dosages of voriconazole (up to 40 mg/kg of body weight/day) and the addition of cimetidine as a cytochrome P450 enzyme inhibitor.

* Corresponding author. Mailing address: National Cancer Institute, CRC 1-5750, 10 Center Drive, Bethesda, MD 20892. Phone: (301) 402-0023. Fax: (301) 480-2308. E-mail: walsht{at}mail.nih.gov

{triangledown} Published ahead of print on 26 January 2009.

Antimicrobial Agents and Chemotherapy, April 2009, p. 1712-1714, Vol. 53, No. 4
0066-4804/09/$08.00+0     doi:10.1128/AAC.01221-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»